CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Pierrel S.p.A. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Pierrel S.p.A.
S.S. Appia 7 Bis 46/48
Phone: +39 0823626111p:+39 0823626111 CAPUA, 81043  Italy Fax: +39 0823626228f:+39 0823626228

This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
Pierrel SpA is an Italy-based company engaged in the pharmaceutical industry. The Company specializes in the pharmaceutical research, development and the manufacture of medicines. It operates through three segments. The Contract Manufacturing segment covers research and development of various types of drugs, such as Tube vials, bottles, ampoules, drops, sprays, tablets and gels. It manufactures the drugs in the production facility in Capua, which consists of warehouses, chemical and microbiological laboratories, offices and utilities buildings. The Pharma segment is active in the development, registration and licensing of new drugs and medical devices. The Tech-driven Contract Research & Development Organization segment provides research of existing drugs for the treatment of rare diseases, among others.
(Source: ARS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202212/31/2022Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board RaffaelePetrone 56 1/1/2018 6/13/2012
Chief Executive Officer, Corporate General Manager FulvioCitaredo 59 1/1/2018
Non-Executive Independent Vice Chairman of the Board RosarioBifulco 67 4/23/2018 9/19/2007
5 additional Officers and Directors records available in full report.

Business Names
Business Name
Encorium USA
IFE Europe GmbH
Pierrel S.p.A.
Pierrel SpA

General Information
Number of Employees: 105 (As of 12/31/2022)
Outstanding Shares: 54,931,506 (As of 8/4/2023)
Stock Exchange: BIT
Fax Number: +39 0823626228


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, March 28, 2024